DOI: 10.1186/s41181-017-0027-7Pages: 1-13

An updated radiosynthesis of [18F]AV1451 for tau PET imaging

1. University of Michigan, Division of Nuclear Medicine, Department of Radiology

Correspondence to:
Peter J. H. Scott
Email: pjhscott@umich.edu

Close

Abstract

Background

[18F]AV1451 is a commonly used radiotracer for imaging tau deposits in Alzheimer’s disease (AD) and related non-AD tauopathies. Existing radiosyntheses of [18F]AV1451 require complex purifications to provide doses suitable for use in clinical imaging studies. To address this issue, we have modified the synthesis of [18F]AV1451 to use only 0.5 mg precursor, optimized the Boc-deprotection step and developed a simplified method for HPLC purification of the radiotracer.

Results

An optimized [18F]AV1451 synthesis using a TRACERLab FXFN module led to high radiochemical yield (202 ± 57 mCi per synthesis) and doses with excellent radiochemical purity (98 ± 1%) and good specific activity (2521 ± 623 Ci/mmol).

Conclusion

An updated and operationally simple synthesis of [18F]AV1451 has been developed that is fully automated and prepares radiotracer doses suitable for use in clinical tau PET studies.

This article is freely available, click here to access the full text/PDF

  • Accepted: May 29, 2017
  • Online: Jun 6, 2017

Article Tools

eanm
EJNMMI Ad